Nuvation Bio Market Sentiment

Nuvation Bio Inc

NUVBNYSE

Trade with Public

$4.69

0.010.21%

最終更新: Oct 15, 12:34 PM

$4.65

-0.03-0.64%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Nuvation Bio Market Sentiment

Market sentiment signals for Nuvation Bio (NUVB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 27.6% short float

Options Flow▲ 0.61 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

18 analysts

Options Flow (P/C)

0.61

More calls — Bullish

49 calls · 30 puts

Avg Consensus PT

$11

+132.0%

Highest Price Target

$21

+347.8%

HC Wainwright & Co.

Lowest Price Target

+6.6%

RBC Capital

Short Interest

27.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 30, 2026	Citigroup	Geoff Meacham—	+155.9%	$12	Initiate	Buy
Sep 16, 2026	Citizens	Silvan Turkcan—	+113.2%	$10 → $10	Maintained	Market Outperform
Sep 16, 2026	Wedbush	David Nierengarten—	+134.5%	$11 → $11	Maintained	Outperform
Aug 21, 2026	Cantor Fitzgerald	Li Watsek—	—	—	Initiate	Overweight
Aug 18, 2026	JP Morgan	Priyanka Grover—	+177.2%	$13	Initiate	Overweight
Aug 7, 2026	RBC Capital	Leonid Timashev—	+326.4%	$19 → $20	Maintained	Outperform
Jul 27, 2026	HC Wainwright & Co.	Robert Burns—	+347.8%	$17 → $21	Maintained	Buy
Jul 23, 2026	Wedbush	David Nierengarten—	+134.5%	$11 → $11	Maintained	Outperform
Jul 7, 2026	RBC Capital	Leonid Timashev—	+305.1%	$20 → $19	Maintained	Outperform
Jul 7, 2026	Truist Securities	Gregory Renza—	+177.2%	$12 → $13	Maintained	Buy
May 5, 2026	RBC Capital	Leonid Timashev—	+326.4%	$20 → $20	Maintained	Outperform
May 5, 2026	Wedbush	David Nierengarten—	+134.5%	$11 → $11	Maintained	Outperform
May 5, 2026	HC Wainwright & Co.	Robert Burns—	+262.5%	$17 → $17	Maintained	Buy
Apr 16, 2026	Wedbush	David Nierengarten—	+134.5%	$11 → $11	Maintained	Outperform
Apr 2, 2026	Wedbush	David Nierengarten—	+134.5%	$11 → $11	Maintained	Outperform
Mar 27, 2026	Wedbush	David Nierengarten—	+134.5%	$11 → $11	Maintained	Outperform
Mar 3, 2026	UBS	Michael Yee—	+49.3%	$10 → $7	Maintained	Neutral
Mar 3, 2026	RBC Capital	Leonid Timashev—	+177.2%	$12 → $13	Maintained	Outperform
Feb 10, 2026	Wedbush	David Nierengarten—	+134.5%	$11 → $11	Maintained	Outperform
Jan 21, 2026	RBC Capital	Leonid Timashev—	+155.9%	$9 → $12	Maintained	Outperform
Jan 12, 2026	HC Wainwright & Co.	Robert Burns—	+262.5%	$18 → $17	Maintained	Buy
Jan 7, 2026	UBS	Michael Yee—	+113.2%	$10	Initiate	Neutral
Dec 11, 2025	HC Wainwright & Co.	Robert Burns—	+283.8%	$10 → $18	Maintained	Buy
Dec 1, 2025	HC Wainwright & Co.	Robert Burns—	+113.2%	$10 → $10	Maintained	Buy
Nov 24, 2025	Truist Securities	Gregory Renza—	+134.5%	$11	Initiate	Buy